Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycobacterium w as Adjunct Therapy in Category-II Pulmonary Tuberculosis
NCT00265226Phase 3Completed
- Sponsor
- Ministry of Science and Technology
- Start
- Mar 2005
- Primary completion
- Dec 2010
- Modality
- Prophylactic Vaccines, Microbiome Therapeutics, Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of MYCIDAC-C in pulmonary tuberculosis (TB), sponsored by Ministry of Science and Technology. Started Mar 2005; status: completed.
02
Drugs
MYCIDAC-C
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT00265226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00265226.